| ADR | adverse drug reaction |
| ACPA | anti-cyclic citrullinated peptide antibody |
| CDAI | clinical disease activity index |
| cs/b DMARDs | synthetic and/or biologic disease-modifying antirheumatic drugs |
| DAS28 | disease activity score |
| DAS28-CRP | disease activity score with C-reactive protein |
| DAS28-ESR | disease activity score with erythrocyte sedimentation rate |
| DMARD | disease-modifying antirheumatic drugs |
| EGA | evaluator global assessment of disease activity |
| EULAR | European Alliance of Associations for Rheumatology |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| GS | gray-scale |
| JAKi | Janus kinases inhibitors |
| LTB | interferon-gamma release assay for latent tuberculosis |
| MSUS | musculoskeletal ultrasonography |
| MTX | methotrexate |
| NHIF | National Health Insurance Fund |
| NYHA | New York Heart Association |
| OMERACT | Outcome Measures in Rheumatology |
| PD | power Doppler |
| PGA | patient global assessment of disease activity |
| RA | rheumatoid arthritis |
| RCT | randomized clinical trials |
| RF | rheumatoid factor |
| SDAI | simplified disease activity index |
| SH | synovial hypertrophy |
| SJC | swollen joint count |
| TJC | tender joint count |
| TOF | tofacitinib |
| USPD | ultrasound power Doppler |
| UPA | upadacitinib |
| US | ultrasound |
| USGS | ultrasound gray-scale |